Treating esophageal cancer is rigorous. Surgery can involve not just the throat, but the chest and abdomen. So how's life after such extensive treatment? Researchers wanted to know and found out.

Developing new drugs takes years of research and costs millions of dollars. That's why scientists often look at the existing pool of pharmaceutical medications as possible solutions for a wide range of diseases.

Progress is being made on most oncology fronts. Unfortunately, brain metastasis remains something medicine hasn't touched in an effective way. Researchers may have found a new opening in resolving the greatest challenge women with advanced breast cancer face.

More and more, we're hearing about unintended consequences and side effects of medicines that have been on the market sometimes for years. Women who have beaten breast cancer can bask in new findings about a medication most of them take.

While the prevalence of a number of cancers is declining, some types are on the rise. The incidence of one of the more difficult forms of liver cancer to treat has tripled over the past 30 years. And researchers are beginning to know why.

MicroRNA are molecules that control genes - particularly the expression (presence) of genes. Recent research illustrates that a microRNA   involved in liver cancer might be a new way to treat the disease.

They are among the most commonly prescribed medications. Now researchers are learning that the health benefits of statins may not stop at lowering cholesterol.

Changes in cell biology are at the heart of cancer. Specifically, when our genes go off key, the cacophony of cancer blares. Scientists are now learning how these genes are reprogrammed.